Proxy adviser ISS recommends Pfizer shareholders reject executive compensation proposal
Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation due to ...
Proxy adviser ISS recommends against Pfizer executive pay proposal
Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation at its ...
Potential Stock Woe Ahead as Pfizer (PFE) Riles Donald Trump
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
Former Pfizer R&D Chief Mikael Dolsten Joins Formation Bio to Chair Drug Picking Committee and Co-Chair its Investment Advisory Committee
Formation Bio, an AI-driven pharmaceutical company revolutionizing drug development, today announced that Mikael Dolsten, MD, PhD, former Chief Scientific Officer and President, Pfizer Research & ...
European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
Fierce Biotech1d
Pfizer, Flagship tap Valo Health for autoimmune offshoot of multibillion-dollar collab
Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...
Explore more
Pfizer (PFE) Receives a Hold from Citi
In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $27.00.
Feds probe tip that Pfizer delayed announcing COVID vaccine’s success until after 2020 election: report
The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
Feds probe disputed tip Pfizer held Covid vaccine results until after 2020 vote: WSJ
President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.
PharmExec10h
Pfizer and Flagship Pioneering Partner to Use AI-Powered Platform for New Drug Development
One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to ...
Why Pfizer Is My Largest Healthcare Position
Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...
Pfizer Stock Slips After Report on Vaccine Timing Probe
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...